Apyx Medical (APYX) Downgraded by Zacks Investment Research to Hold

Apyx Medical stock has undergone multiple analysts rating changes in the recent past.  Apyx Medical Downgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

Shares of Apyx Medical traded down -$0.13 on Wednesday, reaching $13.37. 70664 shares of the stock traded hands, compared to its average volume of 123229. Shares of Apyx Medical were trading at $13.37 on Wednesday. The firm’s 50 day moving average is $11.55 and its 200 day moving average is $10.26.Apyx Medical has a 12 month low of $13.17 and a 12 month high of $14.50. While on yearly highs and lows, Apyx Medical’s today has traded high as $13.76 and has touched $13.17 on the downward trend. See More Analyst Rating at: RATING

Apyx Medical Earnings and What to expect: 

Apyx Medical last issued its earnings results on August 11th, 2021. The reported ($0.12) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.03. The company earned $11.22 million during the quarter, compared to analyst estimates of $8.96 million. Apyx Medical has generated ($0.57) earnings per share over the last year (($0.41) diluted earnings per share). Earnings for Apyx Medical are expected to grow in the coming year, from ($0.54) to ($0.37) per share. Apyx Medical has confirmed that its next quarterly earnings report will be published on Thursday, November 11th, 2021. Apyx Medical will be holding an earnings conference call on Thursday, November 11th at 5:00 PM Eastern. Interested parties can or dial in at 201-612-7415 with passcode “13723897”.

Earnings for Apyx Medical are expected to grow in the coming year, from ($0.54) to ($0.37) per share. The P/E ratio of Apyx Medical is -32.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Apyx Medical is -32.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Apyx Medical has a P/B Ratio of 7.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Apyx Medical (APYX) Moving Average Technical Analysis

5 day Moving Average is $13.58 And 5 day price change is -$0.38 (-2.76%)  with average volume for 5 day average is 64,160. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $12.90 and 20 day price change is $2.26 (20.34%) and average 20 day moving volume is 157,270. 50 day moving average is $11.55  and 50 day price change is $4.31 ( 47.57%)  and with average volume for 50 days is : 97,662. 200 day moving average is $10.26  and 200 day price change is $6.22 (86.99%)  and with average volume for 200 days is : 90,300.

Other owners latest trading in Apyx Medical :

  • On 10/8/2021 shares held by Creative Financial Designs Inc. ADV were 11,599 which equates to market value of $0.16M and appx 0.00% owners of Apyx Medical
  • On 8/23/2021 shares held by Morgan Stanley were 65,158 which equates to market value of $0.67M and appx 0.00% owners of Apyx Medical
  • On 8/17/2021 shares held by Wells Fargo & Company MN were 114,184 which equates to market value of $1.18M and appx 0.00% owners of Apyx Medical
  • In total Institutional ownership equates to Institutional Ownership Percentage: 56.05% for Apyx Medical

See More Analyst Rating at: RATING